{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:46:52Z","timestamp":1792691212854,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:p>Leiomyoma with bizarre nuclei (LM-BN), is a variant of uterine smooth muscle tumor with atypical histologic features. Although some LM-BN share several significant genetic alterations with leiomyosarcoma, including p16 and p53, the underlying tumorigenesis of LM-BN remains largely unknown. As we previously reported, LM-BN can be divided into 2 subtypes, type I and type II, based on different nuclear features. Type I LM-BN have similar histologic features as uterine smooth muscle tumors with fumarate hydratase (FH) alterations. In this study, we examined FH expression and FH mutations in 77 LM-BN (40 type I cases and 37 type II cases). FH expression was examined by immunohistochemistry using S-(2-succino)-cysteine antibodies (2SC, a protein modification associated with FH inactivation and subsequent fumarate accumulation) and FH antibodies (FH gene products). Seventy-two LM-BN tumors underwent Sanger sequencing to detect <jats:italic toggle=\"yes\">FH<\/jats:italic> mutations. We found that 51% (39\/77) of LM-BN showed FH alterations detected by immunohistochemistry with both 2SC and FH. Mutational analysis showed that 21% (15\/72) of LM-BN harbored <jats:italic toggle=\"yes\">FH<\/jats:italic> gene mutations. Further analysis revealed that 85% (34\/40) of those with FH alterations were type I LM-BN while 19% (7\/37) were type II LM-BN. Our findings suggest that over half of histologically diagnosed LM-BN may be related to FH alterations or FH mutations and the majority of these have the characteristic histologic features of type I LM-BN.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000447","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T17:12:02Z","timestamp":1504199522000},"page":"421-430","source":"Crossref","is-referenced-by-count":29,"title":["Fumarate Hydratase Mutations and Alterations in Leiomyoma With Bizarre Nuclei"],"prefix":"10.1097","volume":"37","author":[{"given":"Qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Poropatich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Ubago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Frizzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihua","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/PAS.0b013e3182893f36","article-title":"Atypical leiomyomas of the uterus: a clinicopathologic study of 51 cases","volume":"37","author":"Ly","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/PAS.0b013e318287779c","article-title":"Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up","volume":"37","author":"Mills","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/PAS.0000000000000249","article-title":"Uterine leiomyomas with bizarre nuclei: a clinicopathologic study of 59 cases","volume":"38","author":"Croce","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1002\/cncr.28900","article-title":"Molecular analyses of 6 different types of uterine smooth muscle tumors: emphasis in atypical leiomyoma","volume":"120","author":"Zhang","year":"2014","journal-title":"Cancer"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0b013e3181574d1e","article-title":"The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors","volume":"32","author":"Atkins","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ygyno.2004.09.026","article-title":"Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis","volume":"96","author":"Bodner-Adler","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings","volume":"40","author":"Harrison","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/PAS.0000000000000520","article-title":"Morphology and immunohistochemistry for 2SC and FH aid in detection of fumarate hydratase gene aberrations in uterine leiomyomas from young patients","volume":"39","author":"Joseph","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/modpathol.2013.215","article-title":"Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry","volume":"27","author":"Reyes","year":"2014","journal-title":"Mod Pathol"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.fertnstert.2015.09.034","article-title":"Novel fumarate hydratase mutation in a family with atypical uterine leiomyomas and hereditary leiomyomatosis and renal cell cancer","volume":"105","author":"Wheeler","year":"2016","journal-title":"Fertil Steril"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/PGP.0000000000000276","article-title":"Atypical leiomyoma with features suggesting of fumarate hydratase mutation","volume":"35","author":"Wei","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/PAS.0000000000000646","article-title":"Two subtypes of atypical leiomyoma: clinical, histologic, and molecular analysis","volume":"40","author":"Ubago","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","article-title":"Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases","volume":"18","author":"Bell","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"34219","DOI":"10.1074\/jbc.M703551200","article-title":"Succination of protein thiols during adipocyte maturation: a biomarker of mitochondrial stress","volume":"282","author":"Nagai","year":"2007","journal-title":"J Biol Chem"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status","volume":"225","author":"Bardella","year":"2011","journal-title":"J Pathol"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/PAS.0000000000000626","article-title":"Immunohistochemistry for 2-succinocysteine (2SC) and fumarate hydratase (FH) in cutaneous leiomyomas may aid in identification of patients with HLRCC (hereditary leiomyomatosis and renal cell carcinoma syndrome)","volume":"40","author":"Buelow","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canlet.2005.04.017","article-title":"No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas","volume":"235","author":"Barker","year":"2006","journal-title":"Cancer Lett"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/sj.bjc.6600502","article-title":"Low frequency of somatic mutations in the FH\/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas","volume":"87","author":"Barker","year":"2002","journal-title":"Br J Cancer"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2174\/1566524043359638","article-title":"Hereditary leiomyomatosis and renal cell cancer (HLRCC)","volume":"4","author":"Kiuru","year":"2004","journal-title":"Curr Mol Med"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/PAS.0000000000000703","article-title":"Fumarase-deficient uterine leiomyomas: an immunohistochemical, molecular genetic, and clinicopathologic study of 86 cases","volume":"40","author":"Miettinen","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ijc.21798","article-title":"Analysis of fumarate hydratase mutations in a population-based series of early onset uterine leiomyosarcoma patients","volume":"119","author":"Ylisaukko-oja","year":"2006","journal-title":"Int J Cancer"},{"key":"R23-20230824","first-page":"4554","article-title":"Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families","volume":"62","author":"Kiuru","year":"2002","journal-title":"Cancer Res"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/modpathol.2016.107","article-title":"Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors","volume":"29","author":"Liegl-Atzwanger","year":"2016","journal-title":"Mod Pathol"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2350-9-20","article-title":"The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency","volume":"9","author":"Bayley","year":"2008","journal-title":"BMC Med Genet"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gcc.20291","article-title":"Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features","volume":"45","author":"Christacos","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ajog.2014.01.011","article-title":"Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity","volume":"210","author":"Hodge","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers","volume":"113","author":"Mehine","year":"2016","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201809000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:35:41Z","timestamp":1692840941000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201809000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000447","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}